What is the level of liabilities of Mediwound this year?
Mediwound has a debt balance of 42.34 M USD this year.
Mediwound Liabilities 2025
Mediwound Liabilities
42.34 M USD
Ticker
MDWD
ISIN
IL0011316309
WKN
A110TG
In 2025, Mediwound's total liabilities amounted to 42.34 M USD, a 21.45% difference from the 34.86 M USD total liabilities in the previous year.
Mediwound Aktienanalyse
What does Mediwound do?
Mediwound Ltd is an Israeli company specializing in the development and marketing of therapies for chronic and acute wounds. The company was founded in 2000 and is headquartered in Yavne, Israel. Its history began with the idea of developing an innovative treatment method for burns. The company collaborated closely with the Israeli Ministry of Defense to find a better method for wound treatment. The result was the product NexoBrid, an enzymatic debridement treatment that aims to remove dead tissue from burn wounds to enable faster healing. Mediwound's business model is to develop and market innovative drugs and therapy solutions for wounds. The company operates in several areas, including burn wounds, chronic wounds, and trauma wounds. In the burn wounds sector, Mediwound offers the product NexoBrid, which enzymatically removes dead tissue from burns and eliminates neurotoxic substances that can damage wound healing if left in the tissue for too long. NexoBrid is already approved in several countries, including the USA and European countries. In the chronic wounds sector, Mediwound offers the product EscharEx, which is used to treat chronic wounds such as pressure ulcers, diabetic foot ulcers, and venous leg ulcers. EscharEx also uses an enzymatic approach and aims to remove dead tissue to enable the body's natural healing process. There are plans to launch EscharEx in Europe in the second half of 2021. Mediwound also operates in the trauma wounds sector and received the product MWPC003 in Europe in 2020. It is a novel enzymatic debriding product that can be used in the integrated therapy of complex trauma wounds with additional topical treatment options. Through the development of innovative therapies and drugs, Mediwound has established itself as a reliable partner in wound treatment. The company continues to focus on innovation and plans to expand its product range in the future. Overall, Mediwound Ltd is a groundbreaking company in the field of wound care. The company's products and solutions contribute to faster and more effective wound healing, improving the lives of patients worldwide. Mediwound ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Mediwound's Liabilities
Mediwound's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Mediwound's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Mediwound's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Mediwound's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Mediwound’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Mediwound stock
What were the liabilities of Mediwound compared to the previous year?
The liabilities of Mediwound have increased by 21.45% increased compared to the previous year.
What are the consequences of high debt for investors of Mediwound?
High liabilities can pose a risk for investors of Mediwound, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Mediwound?
Low liabilities mean that Mediwound has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Mediwound affect the company?
An increase in liabilities of Mediwound can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Mediwound affect the company?
A decrease in the liabilities of Mediwound can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Mediwound?
Some factors that can influence the liabilities of Mediwound include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Mediwound so important for investors?
The liabilities of Mediwound are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Mediwound take to modify the liabilities?
To change its liabilities, Mediwound can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Mediwound pay?
Over the past 12 months, Mediwound paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Mediwound is expected to pay a dividend of 0 USD.
What is the dividend yield of Mediwound?
The current dividend yield of Mediwound is .
When does Mediwound pay dividends?
Mediwound pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Mediwound?
Mediwound paid dividends every year for the past 0 years.
What is the dividend of Mediwound?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Mediwound located?
Mediwound is assigned to the 'Health' sector.
Wann musste ich die Aktien von Mediwound kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Mediwound from 8/2/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/2/2025.
When did Mediwound pay the last dividend?
The last dividend was paid out on 8/2/2025.
What was the dividend of Mediwound in the year 2024?
In the year 2024, Mediwound distributed 0 USD as dividends.
In which currency does Mediwound pay out the dividend?
The dividends of Mediwound are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Mediwound
Our stock analysis for Mediwound Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Mediwound Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
